Sign in

Trial site

Inovatyvios alergologijos centras UAB

Vilnius, 06256, LithuaniaEU-13 widening countryNot linked to an institution yet
  • 2closed trials

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 32 trials
Status
  • Completed2 trials
Lead sponsor
  • Areteia Therapeutics Inc.1 trial
  • HAL Allergy1 trial

Closed trials

Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026